GENERAL MILLS, INC. (GIS): what the price assumes

boothcheck covers GENERAL MILLS, INC. (GIS) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-07-26.

Generated: 2026-08-31 · Source: https://boothcheck.com/report/GIS

Headline

FieldValue
TickerGIS
CompanyGENERAL MILLS, INC.
Sector / IndustryConsumer Defensive
Current price$41.40/sh
CompositionSnacks 22% / Cereal 17% / Convenient meals 16% / Pet 15% / Dough 13% / Baking mixes and ingredients 10% / Yogurt 1% / Super-premium ice cream 4% / Other 2%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Trailing margin (depressed year)4.8%
Multiple paid11x mid-cycle operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 6% cost of capital with 4% terminal growth over a 5-year stage (computed at the 6% minimum rate; the CAPM rate 5.8% sits below it).

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.78σ
cohort percentile (of 69 peers)9

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.16x2expensive
Earnings7.10x3expensive
Relative0
Growth2.81x4expensive

Families that call it expensive: Asset, Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.1%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$11.073.74xyesFCF base $1.6B, growth -5% (input: historical growth), terminal g 0.5%, WACC 7.1%, 5yr projection
DCF Exit MultipleGrowth$38.191.08xyesExit EV/EBITDA: 33.7x / 35.7x / 37.7x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 2.0x × TTM revenue — excluded from consensus
Simple DDMGrowth$8.404.93xyesDPS $2.46, g=-15.5% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-25.32noStage 1: -196% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$13.813.00xyesReference only (book value floor): BV/sh $13.81, ROE negative
Two-Stage Excess ReturnAsset$12.433.33xyesReference only (book value with convergence): BV/sh $13.81, ROE converges to ke
Discounted Future Market CapGrowth$22.021.88xyesRev $18.4B, growth -5% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.2x / 1.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$49.360.84xyesNormalized EBIT (5y avg op income, one-time charges added back) $3.68B × (1−21%) / WACC 7.1% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $1.02B × sector EV/EBITDA 14.0x
FCF YieldEarnings$5.837.10xyesFCF $1626.3M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$4.229.81xyesSBC-adj FCF $1.55B (FCF $1.63B − SBC $0.08B) capitalized at Kₑ
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelativenoRevenue $18.42B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
North America Retailoperatingenterprise$11.9b$2.7b operating-incomewithheldunresolved no unit value
North America Petoperatingenterprise$2.5b$501.0m operating-incomewithheldunresolved no unit value
North America Foodserviceoperatingenterprise$2.3b$355.4m operating-incomewithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$13.1b
Net debt / NOPAT (after-tax)5.33x
Net debt / operating income (pre-tax)4.21x
Share count CAGR (buyback)-3.2%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 16.9%); the trailing year was depressed.

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Read the fourth quarter and the fiscal year as two different documents, because they say opposite things.

The year says decline. Net sales fell 5 percent to 18.4 billion dollars, organic sales fell 2 percent, gross margin gave back 100 basis points to 33.6 percent of sales, and reported operating profit dropped 73 percent to 886 million dollars. On its face that is a business losing altitude.

The quarter says something else. Fourth-quarter adjusted gross margin rose 150 basis points to 34.2 percent, adjusted operating margin rose 160 basis points to 15.3 percent, and operating profit grew in every segment: North America Retail up 7 percent, North America Pet up 14 percent, North America Foodservice up 22 percent, International up 81 percent. Four for four is not a mixed quarter. It is what the end of a repricing cycle looks like, and management said as much in setting out the fiscal 2027 plan, describing the price investment work as behind them and the focus now on the topline.

That distinction matters because the two years were shaped by different things. Fiscal 2026 was the year General Mills spent money buying back shelf competitiveness, and the volume evidence suggests the money worked: North America Retail held or gained pound share in 65 percent of its top ten U.S. categories, and North America Pet held dollar share in dog and cat feeding, roughly 80 percent of that segment's retail sales. Price investment that buys share is an investment. Price investment that buys nothing is a discount. This one bought share, in a business whose own 10-K describes the alternative plainly: if it cannot use our scale, marketing expertise, product innovation, knowledge of consumers' needs, and category leadership positions to respond to these demands, our profitability and volume suffer.

The cost programme underneath is unusually specific for a food company. Management has committed to 3 billion dollars of cumulative savings through fiscal 2030, roughly two thirds of it from the long-running productivity programme at about 4 percent of cost of goods sold each year, with at least 750 million dollars targeted in fiscal 2027 alone. Note the arithmetic that makes this interesting: on a business with this revenue base, savings of that size are a multiple of the entire fiscal 2027 profit decline management is guiding to. The savings are not the upside case. They are what holds the floor while the topline turns.

Meanwhile the balance-sheet behaviour has not changed in the way a distressed company's would. The board declared its regular quarterly payout of 61 cents a share in July, extending an uninterrupted record that runs 127 years, and average diluted shares fell 4 percent during fiscal 2026 to 538 million. Buybacks were throttled from 1.2 billion dollars to 500 million, which is the correct move for a company protecting its rating in a heavy investment year rather than a signal of stress. Operating cash flow of 2.2 billion dollars against capital investments of 540 million leaves the payout covered.

Against the shelf it competes on, the reported profitability picture is remarkable mostly for how ordinary General Mills looks inside it. KHC carries a reported operating margin of negative 18.9 percent and a net margin of negative 23.0 percent; CAG runs 0.3 percent at the operating line; SJM shows a negative net margin. This is a category writing down a decade of acquisition prices at once, and the 10-K names the machinery that moved: Our estimates of fair value for goodwill impairment testing are determined based on a discounted cash flow model, and the discount rate that model takes as an input has risen for everyone. A cheaper multiple on assets nobody is impairing would be the anomaly. This is the industry.

Bear Case

The shelf is getting harder, and the evidence is in the competitors' own numbers rather than in commentary. MDLZ grew revenue 7.8 percent and holds a 9.4 percent operating margin; MKC grew 9.5 percent at a 14.9 percent operating margin; POST grew 7.2 percent at 10.1 percent. General Mills grew organic sales by negative 2 percent in fiscal 2026. The companies gaining are the ones selling spices, snacking and adjacent formats; the ones losing are the ones selling centre-of-store staples in boxes. That is not a pricing problem management can fix with a promotion calendar. It is a shift in what people put in the trolley.

The 10-K is unusually candid about the mechanism. General Mills competes not only with other widely advertised branded products, but also with regional brands and with generic and private label products, and warns that in uncertain periods consumers may purchase more generic, private label, and other economy brands and may forego certain purchases. It also lists, among the things that change demand for its products, changes in consumer behavior, trends, and preferences, including weight loss trends. A cereal and baking company naming appetite suppression as a demand variable in its own risk factors is worth pausing on.

Pet was supposed to be the answer to all of that, and Pet is where the accounting broke. General Mills wrote off 1,500 million dollars of goodwill and a further 250 million dollars of brand intangibles, all of which are included within our North America Pet segment, and the 10-K notes that The $1,500 million goodwill impairment charge is not deductible for tax purposes. Segment operating profit for the year was 499 million dollars, essentially flat, on organic sales down 3 percent. The peer data says the category is genuinely difficult rather than uniquely mishandled: SJM's own filing reports that The U.S. Retail Pet Foods segment net sales decreased $159.2 in 2025 with volume and mix taking off 7 percentage points. Two large branded owners, same direction.

Now the price. The market pays roughly ten times the operating profit this business generates before writedowns, which sounds forgiving until you look at what the methods actually reach. Only one family of valuation approach gets to today's quote, and it does so by putting a sector revenue multiple on 18.4 billion dollars of sales, which is a way of valuing a profit problem by ignoring profit. Every other family lands well underneath: the asset-value approaches at under half, the cash-flow projections at under half, and the earnings-power approaches, which capitalise a normalised profit stream with no growth at all, further under still. When the only lens that reaches the quote is the one that does not look at earnings, the quote is doing something other than reflecting earnings.

Fiscal 2027 does not fix it on management's own numbers. The guide calls for organic sales between down 1.5 percent and up 0.5 percent and adjusted operating profit down 8 to 13 percent in constant currency, after roughly nine points of headwind from lapping the extra week, normalising incentive pay and the divestitures. Set that against the payout. General Mills distributed 2.44 dollars a share during fiscal 2026 and guides adjusted diluted earnings of 3.00 to 3.20 dollars for fiscal 2027. The dividend consumes roughly four fifths of the midpoint of that guide, on an adjusted basis that excludes the charges, and the reported basis produced a loss. That is not a dividend at risk next quarter. It is a dividend with very little room to keep rising while profit falls.

The financing picture is the amplifier. Interest, net cost 538.6 million dollars in fiscal 2026, up 3 percent on the year, against reported operating profit of 885.8 million. Borrowings stand near 13.5 billion dollars against 453.8 million of liquid assets, a structure that works fine while adjusted profit is measured in billions and works much less well if the fiscal 2027 decline extends into fiscal 2028. Management has already responded by cutting buybacks from 1.2 billion dollars to 500 million. That is prudent. It is also the first thing that goes, and it was doing real work: share count falling about 3.2 percent a year was flattering per-share results in a year when the business itself shrank.

One boundary is worth naming, because it is not zero. Roughly 512 million dollars of value sits in equity interests held outside the operating segments, principally Cereal Partners Worldwide and Haagen-Dazs Japan. Those carry real recoverable value against a bad operating outcome. They are also currently going the wrong way: the joint ventures produced an after-tax loss of 76.5 million dollars in fiscal 2026 against earnings of 57.6 million a year earlier, driven by General Mills' share of a non-cash goodwill impairment at the cereal venture. The write-downs are not confined to the consolidated accounts.

Valuation

Start with the arithmetic the market is refusing to do. Take today's quote of $36.04, add the borrowings, and the whole enterprise changes hands for roughly ten times the operating profit General Mills earned before a year of writedowns. That multiple is low enough that the price sits below what even a steady mid-single-digit annual decline in operating profit would warrant. Read that carefully: the market is not asking this business to grow. It is pricing in shrinkage, and the question the buyer is answering is whether the shrinkage is worse than that.

The methods do not resolve it, and the shape of their disagreement is the most informative thing here. Only the peer-multiple family reaches today's quote, and it gets there on a sales multiple applied to 18.4 billion dollars of revenue rather than on any earnings figure. Every other family lands underneath. The asset-value approaches, working from book value and the returns earned on it, sit at roughly a third of the quote. The cash-flow projections sit at roughly two fifths, because they are fed a declining revenue trend and dutifully extend it. The earnings-power approaches, which capitalise a normalised profit stream with no growth assumed at all, land further underneath still. That is an unusual pattern for a company priced this cheaply against profit, and it has a single cause: the trailing profit stream those methods use includes a year in which 2,970.8 million dollars ran through the restructuring, transformation and impairment line. Feed a wrecked year into a no-growth model and the model returns a wrecked answer.

So the concrete question is which profit figure describes the business. Reported operating profit for fiscal 2026 was 885.8 million dollars, a 4.8 percent margin against 17.0 percent a year earlier. On the company's own adjusted basis, which strips the 1,500 million dollar goodwill charge, the 250 million dollar brand intangible charge and a 1,000 million dollar valuation loss on the planned Brazil disposal, operating profit was 2.8 billion dollars at a 15.3 percent margin. Those two figures differ by more than three times, and the honest answer is that the second describes the ongoing business while the first describes the year. Management's fiscal 2027 guide starts from the second and calls for it to fall 8 to 13 percent in constant currency, which puts the run rate somewhere near 2.5 billion dollars before any recovery.

The cohort makes the point that this is a category event rather than a company event. KHC reports a negative operating margin and a net margin near negative 23 percent; CAG reports 0.3 percent at the operating line; SJM reports a negative net margin. MDLZ at 9.4 percent and MKC at 14.9 percent are the ones still compounding, and both sell into faster-moving parts of the store. General Mills sits between the two groups: worse than the winners on growth, better than the impairing group on underlying margin. The multiple sits in the lower half of the range these names trade in, which is consistent with that position rather than at odds with it.

The balance sheet is where the argument gets decided. Borrowings near 13.5 billion dollars against 453.8 million dollars of liquid assets is a structure built for a business earning billions in adjusted operating profit, and interest cost 538.6 million dollars during fiscal 2026. Operating cash flow of 2.2 billion dollars still covered the 2.44 dollars a share paid out and left room for the reduced repurchase programme. What it no longer covers comfortably is a second consecutive year of double-digit profit decline, which is precisely why management is targeting 750 million dollars of savings in fiscal 2027 and 3 billion by fiscal 2030. The savings programme is not an efficiency story. It is the pivot the leverage requires.

Catalysts

The most consequential dated event has already happened, and the market has not finished processing it. On July 1, 2026, General Mills reported fiscal 2026 results and simultaneously reset the frame for fiscal 2027: organic net sales guided between down 1.5 percent and up 0.5 percent, adjusted operating profit guided down 8 to 13 percent in constant currency, and adjusted diluted earnings of 3.00 to 3.20 dollars a share. That guide carries roughly nine points of mechanical headwind on operating profit from lapping a 53-week fiscal 2026, normalising corporate incentive pay and absorbing the divestitures, so the underlying business is being asked to do better than the headline decline suggests. The first quarterly print against that guide is the next real information event.

Two structural moves are in flight. The first is the cost programme announced alongside the results: 3 billion dollars of cumulative savings targeted through fiscal 2030, roughly two thirds from the long-running productivity effort at about 4 percent of cost of goods sold annually and the balance from a global transformation initiative covering supply chain redesign and process work, with at least 750 million dollars expected in fiscal 2027. The second is portfolio surgery. The U.S. yogurt business was sold during fiscal 2026 for a gain of about 1 billion dollars, the Canada yogurt business went in fiscal 2025, and a disposal of the Brazil business is planned, already recognised through a 1 billion dollar non-cash pre-tax valuation loss in the fourth quarter. Each completed sale shrinks the revenue base and improves the mix, and the reported growth rate will keep looking worse than the underlying one while that continues.

The routine calendar matters more than usual this year. The board declared a quarterly dividend of 61 cents a share payable August 3, 2026, holding the rate rather than raising it, which for a company that has paid without interruption for 127 years is itself a signal about how management reads fiscal 2027. Watch whether the next declaration moves. Watch too whether repurchases stay near the reduced fiscal 2026 pace of 500 million dollars or step back up; the direction of that number is the clearest available read on management's own confidence in the guide it has just issued.

Peer Cohorts (Per Segment, With Filing Citations)

North America Retail (reported)

North America Pet (reported)

North America Foodservice (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

fiscal 2026 fourth-quarter results release, July 1, 2026 · fiscal 2027 outlook, July 1, 2026 · fiscal 2026 results release, July 1, 2026

View the full interactive GIS report on boothcheck